Skip to main content
. 2015 Sep 24;13(6):1237–1245. doi: 10.1111/iwj.12489

Figure 4.

IWJ-12489-FIG-0004-b

Time course of tissue inhibitors of matrix metalloproteinases (TIMP) 1 and 2 at the time of admission (T0) and during the follow‐up [1 (Tl), 4 (T2), 8 (T3), 12 (T4) and 18 (T5) months after the admission] in deep vein thrombosis (DVT) patients with and without post‐thrombotic syndrome (Groups A and B) and in control non DVT patients (Group C). Data are expressed as ng/mL and are the mean ± standard error medium of three evaluations performed through ELISA test. *P < 0.01 versus Group C; † P < 0.01 versus Group B.